CN1236312C - Human polycystic albumen -1 quantitative determination kit - Google Patents

Human polycystic albumen -1 quantitative determination kit Download PDF

Info

Publication number
CN1236312C
CN1236312C CN 200310108725 CN200310108725A CN1236312C CN 1236312 C CN1236312 C CN 1236312C CN 200310108725 CN200310108725 CN 200310108725 CN 200310108725 A CN200310108725 A CN 200310108725A CN 1236312 C CN1236312 C CN 1236312C
Authority
CN
China
Prior art keywords
bottle
antibody
protein
multisaccate
albumen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200310108725
Other languages
Chinese (zh)
Other versions
CN1544942A (en
Inventor
梅长林
赵海丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN 200310108725 priority Critical patent/CN1236312C/en
Publication of CN1544942A publication Critical patent/CN1544942A/en
Application granted granted Critical
Publication of CN1236312C publication Critical patent/CN1236312C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention relates to a test kit used for quantitatively detecting the content of multisaccate protein-1 in human body fluid, which belongs to the technical field of medical immunology detection. The present invention has the technical scheme that an anti-human multisaccate protein-1 N-end monoclonal antibody and an anti-human multisaccate protein-1 N-end polyclonal antibody are used, a double antibody sandwich enzyme-linked immunosorbent assay (ELISA) method used for quantitatively detecting the content of the multisaccate protein-1 in body fluid and a tissue lysis solution is established by an immunological technique; whether people are sick of autosomal dominant heritability multicystic kidney diseases is judged by contrasting the differences of the content of the multisaccate protein-1. The present invention has important reference value to the diseases for clinical diagnosis and provides an efficient way for preventing and curing the diseases early.

Description

Many capsules of people albumen-1 detection by quantitative kit
Technical field
The present invention relates to Medical Immunology detection technique field, is a kind of double-antibody sandwich elisa kit that is used for many capsules of detection by quantitative people body fluid albumen-1 content.
Background technology
Autosomal dominant polycystic kidney disease (autosomal dominant polycystic kidney disease, ADPKD) be one of human modal lethal single gene inheritance disease, involve all races, at the worldwide incidence of disease is 1/500 ~ 1/1000, has 1,300 ten thousand people to get involved approximately in the whole world.It is characterized in that the bilateral renal cyst is generation of carrying out property and increase, disease is made progress gradually, and the patient that is everlasting promptly develops into end stage renal failure in the later stage in middle age.The kidney failure that ADPKD causes accounts for more than 10% of renal replacement therapy patients sum.This cystic disease harm is very big, does not occur over just kidney, also often involves the outer organ of kidney, causes polycystic liver, ductus pancreaticus and cholangiectasis, colonic diverticula, intracranial aneurysm, heart valve disorders etc.
So far the clinical diagnosis index of ADPKD is not also sought unity of standard in the world, how according to family history, clinical manifestation, the result makes diagnosis in conjunction with imaging examination.The imaging examination of patient Chang Yin routine physical examination is found this disease, and the kidney tumour is often very obvious during discovery.The gene diagnosis result is definitely reliable, but technical conditions, auxiliary examination equipment requirements are higher, complex operation is gone back at present the body fluid diagnosis index of neither one ADPKD clinically, press for one simple, convenient, be easy to promote, the detection method of responsive and special clinical diagnosis ADPKD.
Summary of the invention
In view of ADPKD owing to No. 16 chromosomal PKD1 genes and (or) No. 4 chromosomal PKD2 gene mutations cause that its generation of 85 ~ 90% system is because coded product---the 26S Proteasome Structure and Function caused by abnormal of many capsules albumen-1 (PC-1) of PKD1.So, can be by the content of PC-1 in the detection by quantitative body fluid, tentative diagnosis ADPKD.PC-1 is the transmembrane glycoprotein of an about 460kD of molecular weight, is striden film district relative little endochylema tail with 1 (C end) and is formed by 1 huge extracellular region (N end), 11.The albumen motif of the numerous complicated that extracellular region had has determined the outer part of the born of the same parents of PC-1 that it is exercised the importance of normal physiological function.The present invention sets about PC-1 is detected from the N end of extracellular region.
The present invention utilizes anti-many capsules of people albumen-1N end monoclonal antibody and anti-many capsules of people albumen-1N to hold polyclonal antibody, adopt double-antibody sandwich enzyme-linked immunosorbent assay (ELlSA) method, prepared double-antibody sandwich PC-1-ELlSA kit, with the content of PC-1 in this kit detection by quantitative people body fluid.Judge whether to suffer from ADPKD by the difference that compares PC-1 content in the body fluid, provide an important reference frame for preventing and treating this disease early.
The main agents of kit of the present invention is anti-PC-1N end monoclonal antibody MA7B1 (being coated on the ELISA Plate) and anti-PC-1N end polyclonal antibody PAPC1, the antigen that is used to prepare two kinds of antibody is PC-1 extracellular region N end fusion PC-1-e2, and this fusion is corresponding to the 46th ~ 202 amino acids residue of PC-1.By the content of PC-1N end in the test sample, just can represent the level of PC-1 in being subjected to the sample product.
Kit of the present invention is composed as follows:
1.96 1 of hole ELISA Plate, it has wrapped by anti-people PC-1N end monoclonal antibody MA7B1, and bag is by concentration 5 μ g/ml.
2. sample diluting liquid is 1 bottle, 5ml, and it is the PBS damping fluid that contains 0.05% Tween-20 and 1% bovine serum albumin(BSA).
3. detect 1 bottle of antibody working fluid, 10ml, it contains anti-people PC-1N end polyclonal antibody PAPC1 1 μ g/ml.
4. the enzyme labelled antibody working fluid is 1 bottle, 10ml, and it contains the goat anti-rabbit igg of horseradish peroxidase-labeled.
5. the substrate dilution is 1 bottle, 20ml, and it contains pH5.0 phosphate-citrate salts damping fluid and hydrogen peroxide (H 2O 2).
6. stop buffer is 1 bottle, 5ml, and it is 2M H 2SO 4
7. cleansing solution (20 *) is 1 bottle, 50ml, and it is the pH7.4 phosphate buffer that contains 1.0% Tween-20.
8. standard items 2 are managed, and every pipe contains PC-1-e2 freeze-dried powder 400ng.
9. o-phenylenediamine (OPD) sheet is 3, every 2mg.
10. coordinate paper is 1.
The preparation of kit ELISA Plate of the present invention and each reagent and see the embodiment part for details with the method for PC-1 content in this kit human body liquid sample.
Embodiment
The preparation and the source of each reagent in the people PC-1 detection by quantitative kit
1. standard items albumen is the preparation of fusion PC-1-e2
Standard items albumen behaviour PC-1N end fusion PC-1-e2 freeze-dried powder, this albumen is corresponding to the flank-LRR-flank district of people PC-1 extracellular region N end and the 46th ~ 202 amino acids residue in part WSC district, and purity is more than 97%.The preparation process of this standard items albumen sees the patent of invention " many capsules of people albumen-1N end fusion PC-1-e2 " of application on September 25th, 2003 for details, and number of patent application is 03151184.8.Now its preparation process is summarized as follows:
(1) the total RNA of preparation people's nephridial tissue
Get fresh health adult's nephridial tissue, with Shanghai Hua Shun company total RNA extraction agent box, guanidine isothiocyanate method routinely extracts total RNA.
(2) synthetic primer
Human PKD1 cDNA sequence (GenBank L33243) according to known designs and synthesizes primer.
Forward primer: 5 '-ATA TGCCGCGTCAAC-3 ', its 5 ' end is introduced BamH I restriction enzyme site;
Figure C20031010872500052
Reverse primer: 5 '-TAT
Figure C20031010872500053
CGTGGGCAGCTG-3 ', its 5 ' end is introduced the HindIII restriction enzyme site.
Figure C20031010872500054
(3) RT-PCR amplification PKD1e2 gene
With the total RNA of people's nephridial tissue is template, with the PKD1 cDNA sequence PKD1e2 gene of above-mentioned primer by RT-PCR amplification coding PC-1N end flank-LRR-flank district and part WSC district, its total length 474bp.
(4) construction of expression vector pQE30-PKD1e2 and engineering bacteria M15/pQE30-PKD1e2
With fusion protein expression vector pQE30 (German Qiagen company product, its 5 ' end of reading frame contains the nucleotide sequence of 6 histidines of continuous programming code) and the PKD1e2 gene use BamH I and HindIII double digestion respectively, two kinds of enzymes are cut product glue reclaim back T4DNA ligase connection, transformed competence colibacillus Escherichia coli M15 then, its transformant recombinant plasmid is identified by BamHI/HindIII double digestion and dna sequence analysis, recombinant expression carrier is pQE30-PKD1e2, and engineering bacteria is M15/pQE30-PKD1e2.
(5) abduction delivering of fusion PC-1-e2
Engineering bacteria M15/pQE30-PKD1e2 is 37 ℃ of overnight incubation in the LB nutrient culture media, are seeded in 2 * YT nutrient culture media with 1: 20 volume ratio, continue to be cultured to OD 600Value is 0.5 ~ 0.6, and adding isopropylthiogalactoside (IPTG) to final concentration is 1mM/L, 32 ℃ of abduction deliverings 4 ~ 5 hours.Behind broken bacterium and Ni-NTA Agarose purifying, row SDS-PAGE electrophoresis shows that the fusion protein molecule amount of expressing is 19.0kD, is fusion PC-1-e2.
(6) purifying of fusion Pc-1-e2 and SDS-PAGE analyze
Thalline behind 4 ℃ of centrifugal collection steps (5) abduction delivering, centrifugal after the abundant cracking of 8M/L urea lysate (pH8.0), supernatant and 50% Ni-NTA Agarose (German Qiagen company product) are mixed, with 8M urea pH gradient buffering liquid (pH6.3, pH5.9, pH4.5) washing and wash-out fusion PC-1-e2.12% SDS-PAGE analysis fusioning protein PC-1-e2 analyzes through the albumen thin layer scanning, and this fusion accounts for 47.11% of bacterial protein.
(7) the freeze-drying packing of fusion PC-1-e2
Fusion PC-1-e2 Lowry standard measure with purifying is sub-packed in several 1.5ml plastic centrifuge tubes, and making every pipe PC-1-e2 content is 400ng, then with the freeze dryer freeze-drying to becoming freeze-dried powder, put 4 ℃ of preservations.
2. the preparation of sample diluting liquid
Sample diluting liquid is that to contain its compound method of phosphate (PBS) damping fluid (pH7.4) of 0.05% Tween-20 and 1% bovine serum albumin(BSA) as follows:
(1) preparation PBS damping fluid (pH7.4):
NaCl 8.0g
KH 2PO 4 0.2g
Na 2HPO 4□12H 2O 2.9g
KCl 0.2g
Distilled water adds to 1000ml
Adjust pH to 7.4
(2) preparation contains the PBS damping fluid of 0.05% Tween-20 and 1% bovine serum albumin(BSA)
Tween-20 500 μ l
Bovine serum albumin(BSA) 10g
PBS adds to 1000ml
Be distributed into the 5ml/ bottle, put 4 ℃ of preservations.
3. the preparation of enzyme labelled antibody working fluid
The goat anti-rabbit igg of horseradish peroxidase-labeled is available from U.S. Sigma company.This antibody stoste is sub-packed in the bottle with after 10,000 times of the sample diluting liquid dilutions, and every bottle of 10ml puts 4 ℃ of preservations.
4. the preparation of substrate dilution
(1) preparation phosphate-citrate salts damping fluid (pH5.0):
0.1M citric acid (19.2g/1000ml) 24.3ml
0.2M Na 2HPO 4(28.4g/1000ml) 25.7ml
Distilled water 50ml
(2) preparation substrate dilution: in above-mentioned 100ml phosphate-citrate salts damping fluid, add 30%H 2O 2160 μ l, packing behind the mixing, every bottle of 20ml puts 4 ℃ of preservations.
5. the preparation of stop buffer
Stop buffer is 2M H 2SO 4Get H 2SO 422.2ml, slowly add in the 177.8ml distilled water.Be distributed into every bottle of 5ml.
6. the preparation of cleansing solution (20 *)
Cleansing solution is to contain 1.0% to tell 20 * PBS damping fluid (pH7.4) of soil temperature-20.Its compound method is as follows:
NaCl 160.0g
KH 2PO 4 4.0g
Na 2HPO 4□12H 2O 58.0g
KCl 4.0g
Tween-20 10ml
Distilled water adds to 1000ml
Adjust pH to 7.4 is distributed into the 50ml/ bottle.When the preparation working fluid, only need concentrate is done 20 times of dilutions.
7. the bag quilt and the sealing of the preparation of monoclonal antibody MA7B1 and 96 hole ELISA Plate
Capture antibody is that (antibody subtype is IgG to mouse source anti-people PC-1N end monoclonal antibody MA7B1 1, purity is more than 97%) and its preparation employing hybridoma technology, method sees the patent of invention " anti-many capsules of people albumen-1N end monoclonal antibody MA7B1 " of application on September 25th, 2003 for details, and number of patent application is 03151183.X.Now its preparation process is summarized as follows:
(1) immune Balb/C mouse
With the subcutaneous routinely immune male Balb/C mouse of foregoing fusion PC-1-e2, repeatedly immunity reaches 1: 6,000 ~ 1 to tiring of mouse polyvalent antibody: promptly can be used for preparing monoclonal antibody at 10,000 o'clock.
(2) preparation of monoclonal antibody MA7B1
Getting the successful Balb/c mouse spleen cell of above-mentioned immunity induces down and myeloma cell strain SP2/O carries out Fusion of Cells at Macrogol 4000 (PEG 4000), the HAT selectivity is cultivated and is filtered out fused cell, filter out the hybridoma of the anti-PC-1N end of secretion antibody with indirect enzyme-linked immunosorbent assay (indirect elisa method), carry out cloning with limiting dilution assay again and cultivate, obtain the hybridoma cell strain 7B1 of the anti-PC-1N end of stably excreting monoclonal antibody MA7B1.Routinely this strain 7B1 hybridoma is inoculated in the homology mouse peritoneal, induces generation ascites, extract ascites,, obtain the IgG of purifying by the affinity chromatography purifying 1Type antibody MA7B1.After antibody done freeze-drying and handle the MA7B1 freeze-dried powder, put-80 ℃ and preserve 8. antibody sandwiches and sealing 96 hole ELISA Plate
96 hole ELISA Plate are available from Denmark NUNC company, and the bag quilt and the closed process of antibody are as follows:
(1) coated elisa plate
1. prepare the ELISA Plate bag and be cushioned liquid:
Na 2CO 3 1.59g
NaHCO 3 2.93g
Distilled water adds to 1000ml
Adjust pH to 9.6.
2. be cushioned liquid with bag again monoclonal antibody MA7B1 freeze-dried powder is diluted to final concentration 5 μ g/ml (Lowry method protein quantification), it is added 100 μ l as capture antibody in the every hole of ELISA Plate wrap quilt, put 4 ℃ and spend the night.Can under 4 ℃ of conditions, preserve 6 months after the ELISA Plate sealing that bag is crossed.
(2) sealing
Use 1 * cleansing solution to wash routinely 3 times ELISA Plate, each 3 ~ 5 minutes, dry.Every again hole adds 200 μ l confining liquids (the PBS damping fluid that contains 1%BSA of pH7.4), and 37 ℃ of wet box sealings were spent the night in 2 hours or 4 ℃.
9. detect the preparation of antibody working fluid
Detecting antibody is rabbit source anti-people PC-1N end polyclonal antibody PAPC1 (purity is more than 95%).Be the sero-fast purifying thing that obtains behind the standard items albumen PC-1-e2 immunity new zealand white rabbit.Its preparation process sees the patent of invention " anti-many capsules of people albumen-1N end polyclonal antibody PAPC1 " of on September 25th, 2003 application for details, and number of patent application is 03151182.1 existing its preparation process to be summarized as follows:
With subcutaneous immune 3 the female new zealand white rabbits of foregoing fusion PC-1-e2 (code name is respectively A, B, C), repeatedly immunity to tiring of rabbit polyvalent antibody reaches 1.5 * 10 5 ~2.0 * 10 5, get rabbit anteserum, again with the capable IgG purifying of affinity chromatography, obtain the polyclonal antibody PAPC1 of purifying.After this, with antibody Lowry standard measure, after the packing freeze-drying handle freeze-dried powder, put-80 ℃ of preservations.During preparation antibody working fluid, it is 1 μ g/ml that freeze-dried powder is diluted to concentration with sample diluting liquid, is distributed into every bottle of 10ml.
10. o-phenylenediamine (OPD) sheet
3, every 2mg is available from the magnificent biotech company in Shanghai.
The foundation of people PC-1 detection by quantitative kit typical curve
Set up the typical curve that detects people PC-1 content, this is one step of key of the double-antibody sandwich elisa kit of preparation, assembling detection by quantitative people PC-1 content.The concrete operations step is as follows:
(1) preparation of related reagent
1. cleansing solution: foregoing 20 * cleansing solution is done 20 times of dilutions with distilled water, and adjust pH to 7.4.
2. substrate solution: get foregoing substrate dilution 5ml, add 2mg OPD sheet, be 40% o-phenylenediamine (OPD)-H 2O 2Solution faces with preceding fresh preparation, uses immediately after joining.
(2) foundation of typical curve
1. the dilution of standard items PC-1-e2 and application of sample
To be washed 3 times with cleansing solution by good ELISA Plate with monoclonal antibody MA7B1 bag, each 3 ~ 5 minutes, dry.By certain gradient dilution PC-1-e2 freeze-dried powder, dilute 8 concentration: 1000.00ng/ml, 500.00ng/ml, 250.00ng/ml, 125.00ng/ml, 62.50ng/ml, 31.25ng/ml, 15.63ng/ml, 0.00ng/ml with antibody diluent altogether.The PC1-e2 of every kind of concentration draws 100 μ l and joins in the above-mentioned MA7B1 antibody sandwich hole (every kind of concentration is done 8 multiple holes), 37 ℃ of wet box incubations 2 hours.
2. drip and detect antibody PAPC1
ELISA Plate is washed 3 times with cleansing solution, each 3 ~ 5 minutes, dry.Every hole adds and detects antibody PAPCl 100 μ l in containing the ELISA Plate hole of standard items PC-1-e2,37 ℃ of wet box incubations 60 minutes.
5. dropping enzyme labelled antibody
ELISA Plate is washed 3 times with cleansing solution, each 3 ~ 5 minutes, dry.The every hole of ELISA Plate adds enzyme labelled antibody working fluid (goat anti-rabbit igg of horseradish peroxidase-labeled) 100 μ l, 37 ℃ of wet box incubations 60 minutes.
6. the detection of chromogenic reaction and optical density value
ELISA Plate is washed 3 times with cleansing solution, each 3 ~ 5 minutes, dry.The every hole of ELISA Plate adds 40% OPD substrate solution, 100 μ l, and low frequency oscillation is 15 seconds on the earthquake device, and the reaction of room temperature lucifuge is after 15 minutes, and Dropwise 50 μ l stop buffer in every hole was measured OD with enzyme connection detector in 5 minutes 492Value.
7. set up typical curve
With standard items (PC-1-e2) concentration 1000.00,500.00,250.00,125.00,62.50,31.25,15.63,0.00ng/ml is horizontal ordinate, with the OD of respective concentration 492Be ordinate after deducting blank value, on coordinate paper, map, the typical curve that draws, this curve linear scope is more satisfactory.This kit can detect 88 parts of humoral specimens altogether except that there being 8 holes to be used to set up the typical curve.
Detect the method for PC-1 content in ADPKD patient and the normal control group body fluid with kit of the present invention
One, the preparation of humoral specimen
Whole blood sample is put 4 ℃ of refrigerator overnight, and centrifugal 10 minutes of refrigerated centrifuge (4 ℃) 3000g collects serum ,-80 ℃ of preservations after the packing.For capsule liquid sample in urine and liver, the renal cyst, all at 4 ℃, centrifugal 10 minutes of 3000g collects supernatant, after the packing in-80 ℃ of preservations.
Two, the detection by quantitative of PC-1 in ADPKD patient and the normal control group body fluid
1. preparation reagent
(1) cleansing solution: 20 * cleansing solution is done dilution in 1: 20 with distilled water.
(2) standard items liquid preparation: add the dissolving of 200 μ l distilled waters before using in the standard QC, the PC-1-e2 solution concentration is 2ng/ μ l.
(3) preparation of substrate working fluid: before using the OPD sheet is put into the substrate dilution and dissolve, every adds solution 5ml.
2. the application of sample of standard items
Establish gauge orifice 8 holes on the ELISA Plate, every hole adds sample dilution 100 μ l earlier, adds standard items PC-1-e2 solution 100 μ l again in the 1st hole, moves to the 2nd hole with sample injector sucking-off 100 μ l behind the mixing.Oppose successively and doubly be diluted to the 7th hole, last, sucking-off 100 μ l discard from the 7th hole, and every hole is 100 μ l.The 8th hole is a blank.37 ℃ of wet box incubations 2 hours.
3. the application of sample of humoral specimen
It is some to establish the testing sample hole as required, and humoral specimen is added the testing sample hole respectively, and applied sample amount is 100 μ l/ holes, and negative control hole adds the equal-volume antibody diluent, the rearmounted 37 ℃ of wet box incubations of application of sample 2 hours.
4. drip and detect antibody
Above-mentioned ELISA Plate is washed 3 times with cleansing solution, each 3 ~ 5 minutes, dry.Add 100 μ l in the every hole of ELISA Plate and detect the antibody working fluid, 37 ℃ of wet box incubations 60 minutes.
5. dropping enzyme labelled antibody
Above-mentioned ELISA Plate is washed 3 times with cleansing solution, each 3 ~ 5 minutes, dry.Add enzyme labelled antibody working fluid 100 μ l/ holes again, 37 ℃ of wet box incubations 60 minutes.
6. the detection of chromogenic reaction and optical density value
Above-mentioned ELISA Plate is washed 3 times with cleansing solution, each 3 ~ 5 minutes, dry.The every hole of ELISA Plate adds substrate working fluid 100 μ l, and low frequency oscillation is 15 seconds on the earthquake device, room temperature lucifuge reaction 15 minutes, and Dropwise 50 μ l stop buffer in every hole joined detector bioassay standard product and testing sample OD with enzyme in 5 minutes 492Value.
7. the result calculates and judges
(1) set up typical curve: with the concentration of standard items PC-1-e2 (0.00,15.63,31.25,62.50,125.00,250.00,500.00,1000.00ng/ml) is horizontal ordinate, the OD that microplate reader records 492Value is ordinate after deducting blank value, sets up typical curve.On typical curve, along with the rising of standard items concentration, the OD that records 492Value also increases.
(2) calculating of humoral specimen sample detection value: according to test sample OD 492On above-mentioned typical curve, find corresponding PC-1 content behind the value subduction blank value.As blank well OD 492Mean value is 0.201, test sample OD 492Value is 0.54, and deducting behind the blank value is 0.339, and this value corresponding PC-1 content on typical curve is 82.68ng/ml.
The detection of kit quality inspection index of correlation of the present invention
1. the range of linearity: the range of linearity that this kit detects PC-1 content is 370pg/ml ~ 1000ng/ml.
2. the recovery: the PC-1-e2 of 60ng/ml is added in the test sample, and the recovery is 98.94% (n=8).
3. difference in criticizing: average out to 12.02%.
4. differences between batches: average out to 13.15%.
5. susceptibility: detecting ADPKD urine specimen susceptibility is 91.25%, and detecting ADPKD serum specimen susceptibility is 91.67%.
6. specificity: detecting normal group urine specificity is 90.10%; Detecting the normal group serological specificity is 88.7%.
Through clinic trial, it is as shown in table 1 that this kit detects the result of 110 routine normal persons and 101 routine ADPKD patients serum PC-1 and 114 routine normal persons and 120 routine ADPKD patient's urine PC-1.
The testing result of PC-1 in table 1 serum and the urine (x ± s, ng/ml)
The normal person ADPKD patient P
Serum (ng/ml) 98.76±37.36(n=111) 53.19±16.90(n=101) <0.05
Urine (ng/ml) 47.31±35.71(n=114) 222.10±146.22(n=120) <0.05
N: routine number
Table 1 result shows: in ADPKD patient's urine PC-1 content apparently higher than the normal person, significant difference (p<0.05=; PC-1 content is starkly lower than the normal person among the ADPKD patients serum, significant difference (p<0.05=.Above result shows, utilize kit energy detection by quantitative of the present invention to go out the content of PC-1 in the humoral specimen, clinical detection ADPKD is had higher susceptibility and specificity, be worth, provide an effective way for preventing and treating this disease early to diagnosing this disease to have important references.

Claims (1)

1. many capsules of people albumen-1 detection by quantitative kit, it is composed as follows:
1 of (1) 96 hole ELISA Plate has been wrapped by anti-many capsules of people albumen-1N end monoclonal antibody MA781;
(2) sample diluting liquid is 1 bottle, 5ml, and it is the PBS damping fluid that contains 0.05% Tween-20 and 1% bovine serum albumin(BSA);
(3) detect 1 bottle of antibody working fluid, 10ml, it contains anti-many capsules of people albumen-1N end polyclonal antibody PAPC1 1 μ g/ml;
(4) the enzyme labelled antibody working fluid is 1 bottle, 10ml, and it contains the goat anti-rabbit igg of horseradish peroxidase-labeled;
(5) the substrate dilution is 1 bottle, 20ml, and it contains pH5.0 phosphate-citrate salts damping fluid and hydrogen peroxide;
(6) stop buffer is 1 bottle, and 5ml is 2M H 2SO 4
1 bottle of (7) 20 * cleansing solution, 50ml, it is the pH7.4 phosphate buffer that contains 1.0% Tween-20;
(8) standard items 2 pipes, every pipe contain many capsules of people albumen-1 extracellular region N end fusion PC-1-e2 freeze-dried powder 400ng;
(9) the o-phenylenediamine sheet is 3, every 2mg;
(10) coordinate paper is 1.
CN 200310108725 2003-11-20 2003-11-20 Human polycystic albumen -1 quantitative determination kit Expired - Fee Related CN1236312C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200310108725 CN1236312C (en) 2003-11-20 2003-11-20 Human polycystic albumen -1 quantitative determination kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200310108725 CN1236312C (en) 2003-11-20 2003-11-20 Human polycystic albumen -1 quantitative determination kit

Publications (2)

Publication Number Publication Date
CN1544942A CN1544942A (en) 2004-11-10
CN1236312C true CN1236312C (en) 2006-01-11

Family

ID=34334832

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200310108725 Expired - Fee Related CN1236312C (en) 2003-11-20 2003-11-20 Human polycystic albumen -1 quantitative determination kit

Country Status (1)

Country Link
CN (1) CN1236312C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101553728B (en) * 2006-11-28 2013-02-06 香港大学 The use of granulin-epithelin precursor (GEP) antibodies for detection and suppression of hepatocellular carcinoma (HCC)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102368070A (en) * 2011-07-01 2012-03-07 上海永昶医学诊断用品有限公司 Kit for detecting content of MR-1S (Myofibrillogenesis Regulator-1S) in human plasma and preparation method thereof
CN102507943B (en) * 2011-11-03 2013-04-10 潘世扬 Double antibody sandwiched enzyme-linked immuno sorbent assay (ELISA) kit for detecting non small cell lung cancer (NSCLC), and preparation method for double antibody sandwiched ELISA kit
CN103336125A (en) * 2013-02-28 2013-10-02 苏州和锐医药科技有限公司 Quantitative sH2a detection kit
KR20140110683A (en) * 2013-03-05 2014-09-17 경북대학교 산학협력단 Kit for diagnosing renal disease
CN106282172B (en) * 2015-05-25 2020-05-29 中国福利会国际和平妇幼保健院 STR locus of PKD1 gene and application thereof
CN106282171B (en) * 2015-05-25 2020-05-29 中国福利会国际和平妇幼保健院 STR locus of PKD2 gene and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101553728B (en) * 2006-11-28 2013-02-06 香港大学 The use of granulin-epithelin precursor (GEP) antibodies for detection and suppression of hepatocellular carcinoma (HCC)

Also Published As

Publication number Publication date
CN1544942A (en) 2004-11-10

Similar Documents

Publication Publication Date Title
CN1145639C (en) Subunit respiratory syncytial virus vaccine prepn.
CN102645537A (en) Latex enhanced turbidimetric immunoassay kit for diagnosing gastric diseases or gastric cancer, preparation method thereof and application
CN1867828A (en) Method of separating and assaying adiponectin multimer
CN1703624A (en) Methods and systems for detecting mhc class i and ii binding peptides
CN1062605C (en) Escherichia coli vaccine
CN1183159C (en) Method for diagnosing bone dysbolism
CN1144047C (en) Method for testing or determining HCV core antigen and the agent for same
CN1236312C (en) Human polycystic albumen -1 quantitative determination kit
CN1871518A (en) Method of detecting hepatitis c virus
CN1195869C (en) Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit
CN1344167A (en) Use of antibodies for anticancer vaccination
CN1861633A (en) Toxophasma gondii detecting kit based on recombined antigen
CN1687134A (en) Helicobacter pylori HpaA and monoclonal antibody ureB, immunoassay and diagnosis kit
EP3156798B1 (en) A novel assay for the diagnosis of helminth infections
CN1839319A (en) Composition containing aldolase for analyzing retinal vascular disease and analyzing method thereof
CN1887901A (en) Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit
CN1916633A (en) Method and kit for detecting treponema pallidum
CN1500873A (en) Nereides protease, separating and purifying method and application thereof
CN1671859A (en) Method for identifying individual active entities from complex mixtures
CN1645145A (en) Method and reagent box for inspecting mycelian protein antibody of white candida
CN1427258A (en) Enzyme-linked immunosorbent assay (ELISA) reagent box for assaying low density lipoprotein content in human urine and its preparation method
CN1105185C (en) Process for preparing protein antigen for genetic expression of gene A related to pylorospirobacillus cytotoxin
CN1382735A (en) Somatostatin yolk antibody and its preparing process
CN1195667A (en) Novel antibody, renin-active substance containing same and prorenin assay reagent using the same
CN1185254C (en) First hypervariable region antigen of hepatitis C and fusion antigen

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee